These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 19006114)
1. Safety of spironolactone use in ambulatory heart failure patients. Lopes RJ; Lourenço AP; Mascarenhas J; Azevedo A; Bettencourt P Clin Cardiol; 2008 Nov; 31(11):509-13. PubMed ID: 19006114 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol; 1996 Oct; 78(8):902-7. PubMed ID: 8888663 [TBL] [Abstract][Full Text] [Related]
3. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. Vardeny O; Claggett B; Anand I; Rossignol P; Desai AS; Zannad F; Pitt B; Solomon SD; Circ Heart Fail; 2014 Jul; 7(4):573-9. PubMed ID: 24812304 [TBL] [Abstract][Full Text] [Related]
4. How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? Svensson M; Gustafsson F; Galatius S; Hildebrandt PR; Atar D J Card Fail; 2004 Aug; 10(4):297-303. PubMed ID: 15309695 [TBL] [Abstract][Full Text] [Related]
5. Race influences the safety and efficacy of spironolactone in severe heart failure. Vardeny O; Cavallari LH; Claggett B; Desai AS; Anand I; Rossignol P; Zannad F; Pitt B; Solomon SD; Circ Heart Fail; 2013 Sep; 6(5):970-6. PubMed ID: 23940307 [TBL] [Abstract][Full Text] [Related]
6. Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic. Goland S; Naugolny V; Korbut Z; Rozen I; Caspi A; Malnick S Eur J Intern Med; 2011 Aug; 22(4):424-7. PubMed ID: 21767763 [TBL] [Abstract][Full Text] [Related]
7. Safety of spironolactone use in ambulatory heart failure patients. Kandula P; Shah R Clin Cardiol; 2009 Jun; 32(6):347-8. PubMed ID: 19569078 [No Abstract] [Full Text] [Related]
8. Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease. Pitt B; Bushinsky DA; Kitzman DW; Ruschitzka F; Metra M; Filippatos G; Rossignol P; Du Mond C; Garza D; Berman L; Lainscak M; ESC Heart Fail; 2018 Jun; 5(3):257-266. PubMed ID: 29369537 [TBL] [Abstract][Full Text] [Related]
9. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure. Shah KB; Rao K; Sawyer R; Gottlieb SS J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure). Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B; J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881 [TBL] [Abstract][Full Text] [Related]
11. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure. Tamirisa KP; Aaronson KD; Koelling TM Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880 [TBL] [Abstract][Full Text] [Related]
12. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Pitt B; Bakris G; Ruilope LM; DiCarlo L; Mukherjee R; Circulation; 2008 Oct; 118(16):1643-50. PubMed ID: 18824643 [TBL] [Abstract][Full Text] [Related]
13. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy. Muzzarelli S; Maeder MT; Toggweiler S; Rickli H; Nietlispach F; Julius B; Burkard T; Pfisterer ME; Brunner-La Rocca HP; Am J Cardiol; 2012 Mar; 109(5):693-8. PubMed ID: 22152974 [TBL] [Abstract][Full Text] [Related]